StonvexLoading…
StonvexStonvexStonvexCore line items from CI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $274.90B | $247.12B | $195.26B | $180.52B |
Operating Income | $9.20B | $9.42B | $8.54B | $8.45B |
Net Income | $5.96B | $3.43B | $5.16B | $6.78B |
EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 |
Total Assets | $157.92B | $155.88B | $152.76B | $143.88B |
Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B |
Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 263.46M | 273.79M | 292.50M | 298.68M |